Estimates Revisions Fennec Pharmaceuticals Inc. Toronto S.E.

Stocks

Market Closed - Toronto S.E. 10:25:44 2026-09-21 EDT			5-day change	1st Jan Change
15.00 ^CAD	0.00%		-12.28%	+41.51%

09-17	Fennec Pharmaceuticals Announces Oral Presentation Of Detailed Results From Investigator-Initiated Phase 2 STS-J01 Clinical Study Of Pedmark In Japan At SIOP 2026	CI
08-12	B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.